Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 7,715 | 6,813 | 3,526 | 2,048 | 1,861 |
| Cost of Goods | 1,086 | 894 | 565 | 319 | 332 |
| Gross Profit | 6,629 | 5,919 | 2,961 | 1,729 | 1,529 |
| Operating Expenses | 18,726 | 15,639 | 15,623 | 18,196 | 21,987 |
| Operating Income | -12,012 | -8,827 | -12,097 | -16,148 | -20,125 |
| Interest Expense | 8 | 0 | 0 | 0 | 0 |
| Other Income | 378 | 311 | 788 | 145 | 1,069 |
| Pre-tax Income | -11,641 | -8,516 | -11,309 | -16,003 | -19,056 |
| Net Income Continuous | -11,641 | -8,516 | -11,309 | -16,003 | -19,056 |
| Net Income | $-11,641 | $-8,516 | $-11,309 | $-16,003 | $-19,056 |
| EPS Basic Total Ops | -0.34 | -0.22 | -0.33 | -0.49 | -0.63 |
| EPS Basic Continuous Ops | -0.34 | -0.21 | -0.33 | -0.49 | -0.63 |
| EPS Diluted Total Ops | -0.34 | -0.22 | -0.33 | -0.49 | -0.63 |
| EPS Diluted Continuous Ops | -0.34 | -0.21 | -0.33 | -0.49 | -0.63 |
| EBITDA(a) | $-10,895 | $-11,907 | $-10,982 | $-14,938 | $-18,900 |